METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for METASTATIC CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Dual-Action drug shows promise for kidney cancer patients
Disease control ENROLLING_BY_INVITATIONThis study tests a new medicine called AK112 for people with advanced kidney cancer that has spread. The drug works by helping the immune system fight cancer and blocking blood vessels that feed tumors. About 60 patients will receive the drug every three weeks to see if it shrink…
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 17, 2026 08:15 UTC
-
New drug combo targets hard-to-treat metastatic cancers
Disease control OngoingThis early-phase trial tests a new drug (DS3201) combined with an immunotherapy (ipilimumab) in people with advanced prostate, bladder, or kidney cancer that has spread. The goal is to find the safest dose and see if the combination can help control the cancer. About 65 adults wi…
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 08:04 UTC
-
New hope for kidney cancer patients: which drug combo works best after immunotherapy fails?
Disease control OngoingThis study compares two treatment options for people with advanced kidney cancer that has spread and worsened after prior immunotherapy. About 90 participants will receive either a combination of two drugs (lenvatinib and everolimus) or a single drug (cabozantinib). The goal is t…
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Gut bacteria boosts cancer therapy? new combo trial for kidney cancer
Disease control OngoingThis early-phase study tests whether adding a gut bacteria supplement (CBM588) to standard cancer drugs (nivolumab and cabozantinib) can improve treatment for advanced kidney cancer. About 31 adults with metastatic kidney cancer will take the supplement alongside their regular th…
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 14, 2026 12:02 UTC